Indication
Treatment of the following infections caused by susceptible strains of the designated microorganisms: Middle Ear: Otitis media caused by S. pneumoniae, H. influenzae (beta-lactamase positive and negative strains), B. catarrhalis (beta-lactamase positive and negative strains) and S. pyogenes. Paranasal Sinuses: Sinusitis caused by S. pneumoniae, H. influenzae (beta-lactamase positive and negative strains), and B. catarrhalis (beta-lactamase positive and negative strains). Urinary Tract: Acute uncomplicated cystitis and urethritis caused by E. coli, P. mirabilis, and Klebsiella species. Upper Respiratory Tract: Pharyngitis and tonsillitis caused by S. pyogenes. Lower Respiratory Tract: Acute bronchitis caused by S. pneumoniae, B. catarrhalis (beta-lactamase positive and negative strains) and H. influenzae (beta-lactamase positive and negative strains). Uncomplicated Gonorrhea: Uncomplicated gonorrhea (cervical/urethral and rectal) caused by N. gonorrhoeae, including penicillinase (beta-lactamase-positive) and nonpenicillinase (beta-lactamase-negative) producing strains.
Dosage And Administration
Adult: 1 or 2 capsules (200-400 mg) as once or in 2 divided doses daily for 7-14 days, according to the severity of the infection. Children above 6 months: 8 mg per kg body weight as a single dose or in two divided doses for 7-14 days according to the severity of the infection or as following: 6 months-1 year: 75 mg/day 1-4 years: 100 mg/day 5-10 years: 200 mg/day 11-12 years: 300 mg/day Above 12 years: Adult dose may be administered. Efficacy and safety in infants aged less than six months have not been established.
Side Effects
Cefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials was mild and self-limiting in nature. Gastro-intestinal disturbances: such as Diarrhoea (if severe diarrhoea occurs, Cefixime should be discontinued), changes in the color of stool, nausea, abdominal pain, dyspepsia, vomiting, flatulence have been reported. Central nervous system disturbances: Headache, dizziness, etc. Others: Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible haematological changes; elevation of serum amylase, etc.
Reviews
There are no reviews yet.